Boston University
25 Buick St
Boston
MA
02215
United States
15 articles about Boston University
-
Key findings identify the mechanism behind how senescent cells become zombified, migraine drugs could combat obesity and new AI may identify vaccine hesitancy.
-
Despite having infinitely better global communications, exact figures are hard to come by for COVID-19 fatalities. Here's a look at that story and more COVID-19 news.
-
Details about the U.S. government’s contract with Pfizer for 10 million doses of Paxlovid are emerging, with some unusual elements.
-
Public health officials churn out a lot of statistics related to COVID-19, but it can often be difficult to determine just how accurate they are because there are just so many unreported test results.
-
LUNGevity awards inaugural Health Equity and Inclusiveness Lung Cancer Research Awards
9/13/2021
LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, announced the 2021 award recipients for two new Health Equity and Inclusiveness award programs.
-
New Survey Reveals COVID-19 Vaccine Hesitancy Among Those with Cancer Diagnosis
3/8/2021
Nearly 1 in 3 blood cancer patients and survivors say they are unlikely to get a COVID-19 vaccine, or unsure about it, despite their heightened risk
-
Polyphor receives CARB-X award of up to USD 18.44 million to support development of new antibiotic program
10/14/2020
Polyphor AG, announced that it has received a new and second non-dilutive funding award from CARB-X, a global partnership led by Boston University dedicated to supporting the development of antibacterial products, to diagnose, prevent and treat drug-resistant infections.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 14, 2020.
-
TAXIS Pharmaceuticals Announces CARB-X Award of $3.2 Million, With Potential for an Additional $11.4 Million, to Develop Efflux Pump Inhibitors (EPIs), a New Drug Class to Defeat Multi-Drug Resistant Infections
1/14/2020
CARB-X, a global partnership led by Boston University, is awarding TAXIS Pharmaceuticals, Inc. up to $3.2 million in non-dilutive funding to develop Efflux Pump Inhibitors, representing a new drug class designed to address a major mechanism of multi-drug-resistant Pseudomonas aeruginosa bacteria.
-
Datavant Collaborates with Boston University to Pioneer the Use of Multi-Party Computing for Sharing Insights from Health Data
10/8/2019
Datavant announced that it will be a founding member of the Boston University Data Privacy Collaborative, which aims to bring privacy-preserving technologies such as multi-party computing to bear on real-world applications.
-
CARB-X Strengthens Leadership Team with Appointment of Erin Duffy as Chief of Research and Development (R&D)
9/3/2019
Erin Duffy to lead the growth and oversight of CARB-X’s portfolio of antibiotics, diagnostics, vaccines and other life-saving products addressing antibacterial resistance on a global level
-
Red Tide is a Lethal Replikins Gene Disorder
12/3/2018
Deadly "Blooms" Over Two Years Pre-Outbreak Show Increasingly High Concentration of Gene Replikin Counts
-
Johnson & Johnson Innovation Announces Five-Year Alliance with Boston University to Accelerate Vision of World Without Lung Cancer
6/6/2018
Dr. Avrum Spira Joins Johnson & Johnson Innovation as Global Head, Lung Cancer Initiative to Lead New Cancer Research Center
-
AAPA's Center for Healthcare Leadership and Management Partners with Northeastern University to Offer First PA Leadership and Management Certificate
5/4/2018
The American Academy of PAs' (AAPA) Center for Healthcare Leadership and Management (CHLM) announced a partnership with Northeastern University in Boston to offer a graduate certificate in PA Leadership and Management.